Glyphic Biotechnologies Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Glyphic Biotechnologies

Access the complete profile.

Glyphic Biotechnologies Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	54171 Research & Development in the Physical, Engineering & Life Sciences
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	169 Madison Avenue #2216 New York, NY 10016

Note: Revenues for privately held companies are statistical evaluations.


Glyphic Biotechnologies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Glyphic Biotechnologies's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Glyphic Biotechnologies is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.

Glyphic Biotechnologies Annual Revenue and Growth Rate

Glyphic Biotechnologies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Glyphic Biotechnologies's revenues are gauged from an analysis of company filings.

Glyphic Biotechnologies's Income Statement (based on Industry Averages)

Glyphic Biotechnologies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Glyphic Biotechnologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
February 16, 2024	37	63%	$53 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Glyphic Biotechnologies is developing and marketing. Glyphic Biotechnologies doesn't have any recent trademark applications, indicating Glyphic Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
GLYPHIC BIOTECHNOLOGIES Laboratory devices for detecting genetic sequences; Medical laboratory research instruments for protein and proteome analysis	07/08/2021

See all trademarks and details in the Full Report.

Market Share of Glyphic Biotechnologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Glyphic Biotechnologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
AXIOM SPACE	Houston, TX	1
ADVANCED CLINICAL HOLDINGS	Deerfield, IL	1
PONCE MEDICAL SCHOOL FOUNDATION	Ponce, PR	1
MARSHALL UNIVERSITY	Huntington, WV	1
RESEARCH INNOVATIONS	Alexandria, VA	1
VOYAGER SPACE HOLDINGS	Denver, CO	1
DEEP NORTH	Redwood City, CA	0
EPIRUS	Hawthorne, CA	0

Nearby Competitors

These companies are similar in business line and location to Glyphic Biotechnologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ITI	New York, NY	100
STEMLINE THERAPEUTICS	New York, NY	67
TG THERAPEUTICS	New York, NY	58
POPULATION COUNCIL	New York, NY	53
NEW YORK GENOME CENTER	New York, NY	33
OXFORD NANOPORE TECHNOLOGIES	New York, NY	23

Future Competition: Glyphic Biotechnologies's Fastest Growing Competitors

These companies are in the same general field as Glyphic Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)